Internal Medicine & Patient Care

Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality, patient safety, patient experience and risk management. Dr. Ellahham is a recognized leader in quality, safety, patient experience, risk management and the use of robust performance improvement in improving healthcare delivery. He serves on a number of US and international committees and advisory bodies. He is the Middle East Regional Chair of the Patient Safety Movement Foundation. Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States. Dr. Ellahham is the recipient of prestigious SKMC Infection Prevention Award in 2011 and 2012. He is recognized worldwide for Excellence in infection prevention and control. Dr. Ellahham is Middle East Representative of the JCI Standards Subcommittee and Member on the Editorial Advisory Board of the Joint Commission Journal on Quality and Patient Safety. He is reviewer of HCAC Cardiac Quality and Safety Standards. Dr. Ellahham has been a champion of the use of Lean, Six Sigma and Change Management to improve healthcare quality. He is Lean Six Sigma Master Black Belted. He was the Leader of the First Pilot International Robust Process Improvement (RPI) project by the Joint Commission Center for Transforming Healthcare and several other similar successful performance improvement projects at SKMC. He is Lead Trainer in TeamSTEPPS Lead Trainer. Dr. Ellahham is certified as EFQM 2013 Model assessor and is leading EFQM Excellence Model at SKMC with great success including winning the prestigious Sheikh Khalifa Excellence Award in 2014, Dubai Quality Award in 2015 and Sheikh Khalifa Excellence Golden Award in 2015. Dr. Ellahham is the Executive SKMC sponsor of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) the leading US validated, risk-adjusted, outcomes-based program to measure and improve the quality of surgical care. SKMC is the first multispecialty ACS NSQIP center outside the US. Dr. Ellahham led the publication of, first in the region, annual SKMC outcome books since 2011. He is a strong believer in transparency in health care and external reporting. Dr. Ellahham is a Board-certified internist, cardiologist and vascular medicine senior consultant and continues to care for patients. He received his undergraduate degree in biology and his M.D. from the American University of Beirut. He did his fellowship in Cardiology at the Medical College of Virginia (MCV) in USA. After completing his fellowship, Dr. Ellahham worked in Washington DC in several clinical and leadership positions before moving to UAE in 1988. He led the First AHA GWTG Heart Failure Initiative outside US and was the recipient of the AHA GWTG Award in Wash. DC. His clinical passion and expertise is in the field of heart failure management. He demonstrated great skill and experience in the management of patients with heart failure and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engage local and regional referring providers. He is able to work in a highly matrixed environment, possess strong leadership and organizational skills and have experience to working effectively in a large health system. He is currently Cleveland Clinic Staff and on the Executive Team of The Cleveland Clinic Foundation, in Abu Dhabi, UAE. Dr. Ellahham is a fellow of the American College of Cardiology, American College of Chest Physicians, American College of Physicians, and American Heart Association. He is the Eminent Editor of The Journal of Cardiology & Cardiovascular Therapy. In addition, he serves is on the editorial board of the Joint Commission Journal on Quality and Patient Safety, Open Access Journal of Clinical Trials, Hypertension Today Journal and Focus on Hypertension Journal. Dr. Ellahham is a Distinguished Fellow of the New Westminster College in British Columbia, Canada. Dr. Ellahham is an avid researcher; his research includes lean six sigma, change management, innovation, safety, outcomes research, risk management, safe surgery, heart failure, diabetes mellitus, genetics, cardiac imaging, sports and nutrition. He is a recognized world-leader in these fields. He received several research awards including the DuPont Pharmaceuticals Research Award, ACCP 58th Annual Scientific Assembly, Young Investigator Award; the Alfred Soffer Research Award, ACCP 58th Annual Scientific Assembly, Finalist; the First Young Investigator Award 12th, Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery, and the American Heart Association Get with the Guidelines Award. Dr. Ellahham is on the editorial board of Medical Science, Open Journal of Cardiatic Research and was on the editorial board of The Joint Commission Journal on Quality and Patient Safety. He is also a reviewer for several peer-reviewed journals, including Joint Commission Journal on Quality and Patient Safety, International Journal of Quality & Reliability Management, the Journal of American College of Cardiology, the American Heart Journal, Annals of Internal Medicine, Archives of Internal Medicine, Chest, Circulation, Clinical Cardiology, Chest, Lancet ,Diabetes Care, Archives of Internal Medicine, Endocrinology and Metabolism, European Journal of Heart Failure, Congestive Heart Failure Journal, Journal of Nuclear Cardiology, the Journal of Transplant Coordination, the Journal of Cardiovascular Pharmacology and the Southern Medical Journal, European Journal of Innovation Management and The Anatolian Journal of cardiology.

Cardiology

Dr Sergey Suchkov, MD, PhD. Professor in Medicine. Director, Center for Personalized Medicine, I.M.Sechenov First Moscow State Medical University, and Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born 11.01.1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, Nat Inst of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Inst of Med Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Inst in Moscow; Trainee: NEI, NIH, Bethesda, MD, USA; Chair, Dept for Clin Immunology, Moscow Clin Research Inst (MONIKI); Exe Secretary-in-Chief of the Editorial Board, Biomedical Science International; Director, the Center of Personalized Medicine, I.M.Sechenov First Moscow State Medical Univ, and Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Honours: Secretary General, United Cultural Convention (UCC), Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels, EU.

Personalized, Precision and Translational Medicine, Immunology and Immunogenetics

Dr. Costigliola graduated in Medicine from the University of Naples in 1972 and in Anaesthesiology and Intensive Care from the University of Pisa in 1978. He also attended post-graduated studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession. His professional experience ranges from senior military positions as Chief of Medical Services in the Italian Navy for a number of years, responsibility of the outpatients clinic of the Shape Hospital in Belgium and family practice in Italy and Belgium. Dr. Costigliola practice in Italian, French, English and Spanish. 1.President of E.M.A. (European Medical Association) 2.Member of Editorial Advisory Board of “Psychiatry in primary care journal” 3.Good experience in clinical trials 4.Extensive experience in european health care field 5.Main contractor and participant in many EU projects of dg 22 and dg 5 6.Selected as expert-evaluator in the 5th Framework programme 7.Extensive experience in informatics health programmes 8.Teaching experiences 9.Nationals and internationals conferences as a speaker 10.Publishing experiences

Health Care

William J. Rowe M.D. FBIS ( Fellow British Interplanetary Society ), FACN ( Fellow American College of Nutrition ), is a board certified specialist in Internal Medicine. He received his M.D. at the University of Cincinnati and was in private practice in Toledo, Ohio for 34 years. During that time he supervised over 5000 symptom - limited maximum hospital-based treadmill stress tests. He is a former Assistant Clinical Professor of Medicine at the University of Ohio, School of Medicine at Toledo. He studied 3 world class extraordinary endurance athletes and published their exercise---related magnesium deficiencies. This triggered a 20 year pursuit of the cardiovascular complications of Space flight. He has published in LANCET that extraordinary, unremitting endurance exercise can injure a perfectly normal heart. Of only 4 space syndromes, he has published 2: "The Apollo 15 Space Syndrome" and "Neil Armstrong Syndrome." He published Neil Armstrong's probable lunar acute heart failure. He has been listed in the Marquis Whos Who of the World from 2002-2009,2013, 2014, 2015, 2016, 2017.

Cardiovascular complications of space flight, focusing particularly on catecholamine cardiomyopathy, impaired thermoregulation and “Neil Armstrong Syndrome.: severe dyspnea, thirst, tachycardia with the latter corrected by restoring plasma volume.

Dimitrios H. Roukos, MD, PhD, is the founding director of Centre for Biosystems and Genome Network Medicine in the Ioannina University, School of Medicine. Assessing the current and future unmet needs of traditional clinical research and single-gene linear transcription-based targeted therapy, he has moved to clinical cancer genome sequencing, regulatory molecular networks and nonlinear transcription. Comprehensive intrapatient landscapes of genomic alterations represent his current research focus. With over 232 papers, including 80 on next-generation sequencing and 32 on precision medicine-oncology, 8,130 citations, h-index of 70, reviewer for high impact journals, editorial board member in more then 25 high-impact journal, lecturer and organizing committee member for international conferences, he is an internationally recognized leading expert of precision cancer genome medicine.

precision cancer genome medicine

Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil. Moreover, he is a member of the Board of Advisors, former COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty, a member of the Board of Advisors, former Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also serves as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and is a member of the Board of Advisors and former Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense and former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy. Alejandro De la Parra Solomon is on Google+, Facebook, and on LinkedIn.

Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development

Biography (Max. 250 words) Katerina Ristoska, MD is a graduate of Medical Faculty, Skopje, Republic of Macedonia, where she also attended her specialization in internal medicine. Dr.Ristoska trained at Medical Faculty, Skopje, at the Department of Nephrology during her residency. During her residency, she was able to provide superior care and consulatation that resulted in an overall improvement of the department's patient satisfaction quotien. She complited training in dialysology and focused on the patient treatment and reevaluated several methods of therapy management dependent on individual patent history and efficacy of previous treatment. Dr.Ristoska has been practicing and attended her undergraduate studies in the Department of Cardiology at Medical Faculty in Skopje. She is currently author and coauthor of 57 publication at the international congresses at home and abroad, as same in the several other journals.She was contributor on two multicentric studies of pharmaceutical company"Krka-Farma" DOOEL Skopje.Dr.Ristoska is Fellow of New Westminster College, Vancouver, British Columbia, Canada. She is the Member of The Macedonian Association of internal medicine, ESC, EAPCI, HFA, EACVI, EAPC, ACCA. She is also the Member of ESC Council on Cardiovascular Nursing and Allied Professions, ESC Council on Hypertension, ESC Council on Valvular Heart Disease, the Member of Working Group on Grown-up Congenital Heart Disease, the Member of Working Group on Aorta & Peripheral vascular disease. Dr.Ristoska is the Member of ERA – EDTA Diabesity Group, ERA – EDTA EUREKA -M Working Group of European renal and Cardiovascular medicine, ERA - EDTA CKD- MBD Working Group. She is also an accredited examiner of a doctor's professional exam for obtaining a work license. After her extensive work experience in a children's dispensary, emergency unit, surgery unit, private health sector, she is currently working in the hemodialysis center of Sistina nephroplus. Ristoska acts as a volunteer in many humanitarian organizations dealing with women's health, child health, animal protection. Currently, Dr.Ristoska holds certification from the Macedonian Board of Internal Medicine. Research Interest

Internal Medicine

Mojtaba Mafi is a physician/Medical Doctor. He received M.D. degree from Tehran university school of Medicine with honors and passed successfully many post graduate Medical education programs approved by Medical Sciences University. He worked clinically in Neurosurgery ward Shariati hospital for Thesis on Brain tumors and Meningioma for 6 years till 2008. He is now active in clinical setting and scientific field. Dr Mojtaba Mafi is invited speaker in Global and European neurosurgery and neurology conferences in Rome, Italy and London. He is invited editorial board member of psychology and neuroscience journal. He is speaker of world congress on neuronal synchronization, London 2018 and speaker of International Neuro oncology conference in Dubai, September 2018. He is honourable speaker of 26th International Neurology conference in Japan.

Neuroscience

Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of: Applied Clinical Cognitive Neuropsychology from USA. Prof. Dr. Aleezaadeh Completed his PhD Degrees in Psychology at the USA. He completed his master's Degree in Clinical Psychology at I. R. of the IRAN and bachelor's Degree in General Psychology at I. R. of the IRAN. He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (GreenLake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.

Cognitive Sciences, Cognitive Neurosciences, Neuroimaging, Applied Clinical Neuropsychology, Brain ( Cranial ) Imaging, Traditional Medicine, Homeopathic Medicine and, Combination of Medical And, Psychological trends for eradicating illnesses / sicknesses, Psychology, Cognitive Neuropsychology